Stockscreener 앱 받기
16.76
0.12%
-0.02
시간 외 거래:
16.74
-0.02
-0.12%
전일 마감가:
$16.78
열려 있는:
$16.79
하루 거래량:
44,681
Relative Volume:
1.02
시가총액:
$179.60M
수익:
$19.85M
순이익/손실:
$-12.75M
주가수익비율:
-6.8971
EPS:
-2.43
순현금흐름:
$-21.94M
1주 성능:
+2.38%
1개월 성능:
-2.05%
6개월 성능:
-2.44%
1년 성능:
+99.52%
1일 변동 폭
$16.56
$16.81
1주일 범위
$15.53
$16.85
52주 변동 폭
$8.22
$24.00
Mediwound Ltd Stock (MDWD) Company Profile
MDWD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| MDWD | 16.76 | 179.60M | 19.85M | -12.75M | -21.94M | -2.43 |
| VRTX | 450.37 | 115.10B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 596.74 | 35.07B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.80 | 32.20B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 25.09B | 3.30B | -501.07M | 1.03B | 11.54 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-12-22 | 개시 | Maxim Group | Buy |
| 2022-07-18 | 재개 | Oppenheimer | Outperform |
| 2020-09-23 | 개시 | BTIG Research | Buy |
| 2016-11-28 | 개시 | Aegis Capital | Buy |
| 2016-08-17 | 개시 | Wells Fargo | Outperform |
| 2014-04-16 | 개시 | Oppenheimer | Outperform |
모두보기
Mediwound Ltd 주식(MDWD)의 최신 뉴스
MediWound Ltd.'s (NASDAQ:MDWD) institutional investors lost 10% last week but have benefitted from longer-term gains - Simply Wall St
MediWound (MDWD) to Release Earnings on Tuesday - MarketBeat
MediWound to Discuss New Share Incentive Plan - TipRanks
MediWound to Report Third Quarter 2024 Financial Results - GlobeNewswire
MediWound Q3 2024 Earnings Call Scheduled for November 26: What to Expect | MDWD Stock News - StockTitan
99,994 Shares in MediWound Ltd. (NASDAQ:MDWD) Bought by ARK Investment Management LLC - MarketBeat
MediWound Ltd. (NASDAQ:MDWD) is Rosalind Advisors Inc.'s 5th Largest Position - MarketBeat
MediWound (STU:M8W) Financial Strength : 6 (As of Jun. 2024) - GuruFocus.com
How the (MDWD) price action is used to our Advantage - Stock Traders Daily
MediWound Is A Healthy Investment (NASDAQ:MDWD) - Seeking Alpha
MediWound's (NASDAQ:MDWD) investors will be pleased with their stellar 125% return over the last year - Yahoo Finance UK
Rosalind Advisors, Inc. Increases Stake in MediWound Ltd - Yahoo Finance
(MDWD) Pivots Trading Plans and Risk Controls - Stock Traders Daily
MediWound (NASDAQ:MDWD) Rating Reiterated by HC Wainwright - Defense World
Trading (MDWD) With Integrated Risk Controls - Stock Traders Daily
MediWound shares maintain buy rating on new study plans - Investing.com India
MediWound shares maintain buy rating on new study plans By Investing.com - Investing.com South Africa
MediWound (NASDAQ:MDWD) Earns Buy Rating from HC Wainwright - MarketBeat
MediWound advances EscharEx in Phase II VLU study By Investing.com - Investing.com Australia
MediWound advances EscharEx in Phase II VLU study - Investing.com India
MediWound Announces Phase II Head-to-Head Study Evaluating - GlobeNewswire
MediWound to Participate in the 2024 Maxim Healthcare Virtual Summit - The Manila Times
(MDWD) On The My Stocks Page - Stock Traders Daily
Rhumbline Advisers Purchases Shares of 8,440 MediWound Ltd. (NASDAQ:MDWD) - Defense World
Objective long/short (MDWD) Report - Stock Traders Daily
TD Cowen maintains Buy rating on MediWound shares with no price target change - Investing.com
MediWound (NASDAQ:MDWD) Stock Price Crosses Below 200-Day Moving Average of $16.99 - MarketBeat
(MDWD) Long Term Investment Analysis - Stock Traders Daily
MediWound (NASDAQ:MDWD) Shares Cross Above 50 Day Moving Average of $18.20 - MarketBeat
MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
Critical Comparison: MediWound (NASDAQ:MDWD) versus Jinhua Marine Biological (OTCMKTS:JNMB) - Defense World
MediWound Ltd.'s (NASDAQ:MDWD) top owners are retail investors with 38% stake, while 28% is held by institutions - Yahoo Finance
MDWDMediWound Ltd. Latest Stock News & Market Updates - StockTitan
MediWound Ltd. Forecasted to Post Q3 2024 Earnings of ($0.49) Per Share (NASDAQ:MDWD) - MarketBeat
Brokers Set Expectations for MediWound Ltd.’s Q3 2024 Earnings (NASDAQ:MDWD) - Defense World
MediWound (FRA:M8W) Median PS Value : €30.03 (As of Aug. 24, 2024) - GuruFocus.com
MDWD (MediWound) Free Cash Flow : $-22.27 Mil (TTM As of Jun. 2024) - GuruFocus.com
HC Wainwright Reiterates Buy Rating for MediWound (NASDAQ:MDWD) - Defense World
MediWound Ltd. (NASDAQ:MDWD) Forecasted to Earn FY2027 Earnings of $1.28 Per Share - Defense World
Equities Analysts Offer Predictions for MediWound Ltd.'s FY2027 Earnings (NASDAQ:MDWD) - MarketBeat
MediWound and Vericel win FDA paediatric label expansion for NexoBrid - Medical Device Network
MediWound shares hold Buy rating with steady target on expansion By Investing.com - Investing.com Australia
MediWound Second Quarter 2024 Earnings: EPS Misses Expectations - Simply Wall St
MediWound Announces U.S. Food and Drug Administration - GlobeNewswire
Vericel, MediWound climb on FDA's expanded approval for skin treatment - XM
MediWound’s NexoBrid Gains FDA Pediatric Approval - TipRanks
Mediwound Ltd (MDWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
3.55%
자본화:
|
볼륨(24시간):